1. Home
  2. STVN vs NOV Comparison

STVN vs NOV Comparison

Compare STVN & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • NOV
  • Stock Information
  • Founded
  • STVN 1949
  • NOV 1862
  • Country
  • STVN Italy
  • NOV United States
  • Employees
  • STVN N/A
  • NOV N/A
  • Industry
  • STVN Containers/Packaging
  • NOV Metal Fabrications
  • Sector
  • STVN Consumer Discretionary
  • NOV Industrials
  • Exchange
  • STVN Nasdaq
  • NOV Nasdaq
  • Market Cap
  • STVN 5.7B
  • NOV 5.4B
  • IPO Year
  • STVN 2021
  • NOV 1996
  • Fundamental
  • Price
  • STVN $19.27
  • NOV $11.86
  • Analyst Decision
  • STVN Buy
  • NOV Buy
  • Analyst Count
  • STVN 7
  • NOV 16
  • Target Price
  • STVN $26.93
  • NOV $19.60
  • AVG Volume (30 Days)
  • STVN 365.9K
  • NOV 5.5M
  • Earning Date
  • STVN 03-06-2025
  • NOV 04-28-2025
  • Dividend Yield
  • STVN 0.29%
  • NOV 2.24%
  • EPS Growth
  • STVN N/A
  • NOV N/A
  • EPS
  • STVN 0.45
  • NOV 1.60
  • Revenue
  • STVN $1,143,012,735.00
  • NOV $8,870,000,000.00
  • Revenue This Year
  • STVN $8.60
  • NOV $0.52
  • Revenue Next Year
  • STVN $12.43
  • NOV $2.98
  • P/E Ratio
  • STVN $45.67
  • NOV $8.36
  • Revenue Growth
  • STVN 1.72
  • NOV 3.34
  • 52 Week Low
  • STVN $16.56
  • NOV $13.36
  • 52 Week High
  • STVN $31.41
  • NOV $21.20
  • Technical
  • Relative Strength Index (RSI)
  • STVN 41.47
  • NOV 26.58
  • Support Level
  • STVN $20.11
  • NOV $14.79
  • Resistance Level
  • STVN $21.21
  • NOV $15.48
  • Average True Range (ATR)
  • STVN 1.02
  • NOV 0.47
  • MACD
  • STVN -0.15
  • NOV -0.22
  • Stochastic Oscillator
  • STVN 8.51
  • NOV 1.10

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About NOV NOV Inc.

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

Share on Social Networks: